observation:observation

2 trials

Sponsors

The Third Affiliated Hospital of the Second Military Medical University of the Chinese people's Liberation Army, Shanghai Changzheng Hospital

Conditions

HCC combined with microvascular tumor thrombusMultiple myeloma

Phase 2

Study on the effect of adjuvant PD-1 monoclonal antibody in patients with hepatocellular carcinoma complicated with microvascular tumor thrombus

RecruitingChiCTR2000037655

The Third Affiliated Hospital of the Second Military Medical University of the Chinese people's Liberation ArmyHCC combined with microvascular tumor thrombus

Start: 2020-09-01Updated: 2020-11-02

Unknown Phase

The significance of minimal residual disease exmination on the multiple myeloma maintain treatment

Active, not recruitingChiCTR-IOR-17010695

Shanghai Changzheng HospitalMultiple myeloma

Start: 2017-04-01Updated: 2017-04-18

Related Papers

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.

2024-01-1983 citations